Guard Therapeutics (Sweden) Buy Hold or Sell Recommendation
| GUARD Stock | SEK 29.80 2.60 9.56% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Guard Therapeutics International is 'Strong Sell'. Macroaxis provides Guard Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GUARD positions. The advice algorithm takes into account all of Guard Therapeutics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Guard Therapeutics' buy or sell advice are summarized below:
Real Value 22.34 | Hype Value 29.8 | Market Value 29.8 | Naive Value 34.45 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Guard Therapeutics International given historical horizon and risk tolerance towards Guard Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Guard Therapeutics International, the advice is generated through an automated system that utilizes algorithms and statistical models.
Guard |
Execute Guard Therapeutics Buy or Sell Advice
The Guard recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Guard Therapeutics International. Macroaxis does not own or have any residual interests in Guard Therapeutics International or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Guard Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Guard Therapeutics Trading Alerts and Improvement Suggestions
| Guard Therapeutics had very high historical volatility over the last 90 days | |
| Guard Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (82.03 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Guard Therapeutics International has accumulated about 188.6 M in cash with (77.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44. | |
| Roughly 30.0% of the company shares are held by company insiders |
Guard Therapeutics Returns Distribution Density
The distribution of Guard Therapeutics' historical returns is an attempt to chart the uncertainty of Guard Therapeutics' future price movements. The chart of the probability distribution of Guard Therapeutics daily returns describes the distribution of returns around its average expected value. We use Guard Therapeutics International price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Guard Therapeutics returns is essential to provide solid investment advice for Guard Therapeutics.
| Mean Return | 0.34 | Value At Risk | -7.5 | Potential Upside | 12.39 | Standard Deviation | 6.08 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Guard Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Guard Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Guard Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Guard Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Guard stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.45 | |
β | Beta against NYSE Composite | -2.07 | |
σ | Overall volatility | 5.37 | |
Ir | Information ratio | 0.04 |
Guard Therapeutics Volatility Alert
Guard Therapeutics International is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Guard Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Guard Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Guard Therapeutics Fundamentals Vs Peers
Comparing Guard Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Guard Therapeutics' direct or indirect competition across all of the common fundamentals between Guard Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Guard Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Guard Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Guard Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Guard Therapeutics to competition |
| Fundamentals | Guard Therapeutics | Peer Average |
| Return On Equity | -1.53 | -0.31 |
| Return On Asset | -0.75 | -0.14 |
| Current Valuation | 120.17 M | 16.62 B |
| Shares Outstanding | 503.08 M | 571.82 M |
| Shares Owned By Insiders | 30.30 % | 10.09 % |
| Shares Owned By Institutions | 35.55 % | 39.21 % |
| Price To Book | 2.97 X | 9.51 X |
| EBITDA | (82.03 M) | 3.9 B |
| Net Income | (82.03 M) | 570.98 M |
| Cash And Equivalents | 188.6 M | 2.7 B |
| Cash Per Share | 0.44 X | 5.01 X |
| Debt To Equity | 0 % | 48.70 % |
| Current Ratio | 10.80 X | 2.16 X |
| Book Value Per Share | 0.30 X | 1.93 K |
| Cash Flow From Operations | (77.59 M) | 971.22 M |
| Earnings Per Share | (0.34) X | 3.12 X |
| Target Price | 2.55 | |
| Number Of Employees | 10 | 18.84 K |
| Beta | 1.55 | -0.15 |
| Market Capitalization | 624.87 M | 19.03 B |
| Total Asset | 190.44 M | 29.47 B |
| Net Asset | 190.44 M |
Guard Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Guard . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Guard Therapeutics Buy or Sell Advice
When is the right time to buy or sell Guard Therapeutics International? Buying financial instruments such as Guard Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Guard Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Materials ETFs Thematic Idea Now
Materials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Materials ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Materials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Guard Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Guard Therapeutics information on this page should be used as a complementary analysis to other Guard Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Guard Stock analysis
When running Guard Therapeutics' price analysis, check to measure Guard Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guard Therapeutics is operating at the current time. Most of Guard Therapeutics' value examination focuses on studying past and present price action to predict the probability of Guard Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guard Therapeutics' price. Additionally, you may evaluate how the addition of Guard Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |